Solid Biosciences (SLDB) Amortizatization of Intangibles (2017 - 2026)

Solid Biosciences' (SLDB) quarterly Amortizatization of Intangibles came in at $619000.0 in Q1 2026, up 98.4% year-on-year from $312000.0 in Q1 2025, and down 17.14% quarter-over-quarter from $747000.0 in Q4 2025.

Solid Biosciences (SLDB) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends

Solid Biosciences has disclosed Amortizatization of Intangibles across 10 years of filings, most recently posting $619000.0 for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $619000.0, up 98.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (down 35.17% YoY), and the FY2025 annual result was $1.9 million, down 47.83% from the prior year.
  • Amortizatization of Intangibles came in at $619000.0 for Q1 2026 at Solid Biosciences, down from $747000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q3 2024 to a low of -$371000.0 in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $488000.0 (2025), against an average of $485882.4.
  • Across the five-year window, Amortizatization of Intangibles jumped 5688.24% in 2023 and sank 72.93% in 2025, its largest moves.
  • Solid Biosciences' Amortizatization of Intangibles stood at $276000.0 in 2022, then jumped by 317.03% to $1.2 million in 2023, then sank by 30.23% to $803000.0 in 2024, then retreated by 6.97% to $747000.0 in 2025, then declined by 17.14% to $619000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $619000.0 (Q1 2026), $747000.0 (Q4 2025), and $327000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 13,267.00
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 Solid Biosciences 789.54 Mn 408.86 Mn - 619,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 619,000.00
Mar 31, 2026 619,000.00
Dec 31, 2025 747,000.00
Dec 31, 2025 747,000.00
Sep 30, 2025 327,000.00
Sep 30, 2025 327,000.00
Jun 30, 2025 488,000.00
Jun 30, 2025 488,000.00
Mar 31, 2025 312,000.00
Mar 31, 2025 312,000.00
Dec 31, 2024 803,000.00
Dec 31, 2024 803,000.00
Sep 30, 2024 1.21 Mn
Sep 30, 2024 1.21 Mn
Jun 30, 2024 1.04 Mn
Jun 30, 2024 1.04 Mn
Mar 31, 2024 540,000.00
Mar 31, 2024 540,000.00
Dec 31, 2023 1.15 Mn
Dec 31, 2023 1.15 Mn